After license deal for letermovir: Head-to-head phase 2 trial initiated by AiCuris to demonstrate superiority of its novel drug pritelivir vs. valacyclovir for treatment of genital herpes
- 27.11.2012, 09:00
- Kategoria: Zdrowie i styl życia
- Źródło: PAP